Shaanxi Kanghui Pharmaceutical Hits Day Low at CNY 32.37 Amid Price Pressure

Shaanxi Kanghui Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 10.01% to touch an intraday low of CNY 32.37. This performance stands in stark contrast to the China Shanghai Composite, which saw a modest gain of 0.85% on the same day. Over the past week, Shaanxi Kanghui has faced a steep decline of 17.21%, while its monthly performance reflects a drop of 28.4%. Despite these short-term challenges, the company has shown a notable annual performance increase of 46.07%, outperforming the China Shanghai Composite's 7.41% gain over the same period. However, the company's financial metrics indicate underlying issues. Shaanxi Kanghui has reported operating losses and a weak long-term fundamental strength, with a debt-to-equity ratio averaging at 0.99. The company has also faced negative results for the last four consecutive quarters, with a return on equity of -52.59%. As a small-cap player in the pharmaceuticals and biotechnology sector, Shaanxi Kanghui's current market cap stands at CNY 1,925 million.